Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

p21-activated kinase 4 as a switch between caspase-8 apoptosis and NF-κB survival signals in response to TNF-α in hepatocarcinoma cells.

P-21 Activated Kinases in Liver Disorders

Inhibition of RIPK 1 expression and facilitation of TRAIL-induced hepatocellular carcinoma cell apoptosis by miR-141

Knockdown of PAK1IP1 can induce CASP-3-dependent pyroptosis to inhibit the progression of hepatocellular carcinoma

Pim-2 Activates API-5 to Inhibit the Apoptosis of Hepatocellular Carcinoma Cells Through NF-κB Pathway

PAK4-relevant Proliferation Reduced by Cell Autophagy Via P53/mtor/p-Akt Signaling.

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Tumor Suppressive Function of P21-Activated Kinase 6 in Hepatocellular Carcinoma*

Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor

P21 Activated Kinase 4 and Tumor

NR4A1-induced Increase in the Sensitivity of a Human Gastric Cancer Line to TNFα-mediated Apoptosis is Associated with the Inhibition of JNK/Parkin-dependent Mitophagy.

The Preventative Effect of Akt Knockout on Liver Cancer Through Modulating NF-κB-regulated Inflammation and Bad-related Apoptosis Signaling Pathway.

Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.

Regulation of Cellular Apoptosis by Palmitic Acid and TNF‐alpha: Involvement of Signal Transduction Pathways from PKR to Bcl‐2

Tumor Necrosis Factor Α-Induced Protein 1 As a Novel Tumor Suppressor Through Selective Downregulation of CSNK2B Blocks Nuclear Factor-Κb Activation in Hepatocellular Carcinoma.

P21-Activated Protein Kinase 4 (pak4) Interacts with the Keratinocyte Growth Factor Receptor and Participates in Keratinocyte Growth Factor-Mediated Inhibition of Oxidant-Induced Cell Death

PAK1 Promotes Proliferation, Migration and Invasion of Hepatocellular Carcinoma by Facilitating EMT Via Directly Up-Regulating Snail.

Glycogen Synthase Kinase-3Β Regulates Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (Trail)-Induced Apoptosis Via the NF-κB Pathway in Hepatocellular Carcinoma.

PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway

Tβ4 suppresses lincRNA-p21-mediated hepatic apoptosis and fibrosis by inhibiting PI3K-AKT-NF-κB pathway

NFATc1 is a Tumor Suppressor in Hepatocellular Carcinoma and Induces Tumor Cell Apoptosis by Activating the FasL‐mediated Extrinsic Signaling Pathway